STOCK TITAN

Five Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Five Prime Therapeutics (NASDAQ: FPRX) announced that CEO Tom Civik and CMO Helen Collins, M.D. will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 10:00 a.m. ET.

The live audio webcast can be accessed from the 'Events & Presentations' section of the company’s website. An archived replay will be available for 30 days after the conference.

Five Prime is dedicated to developing innovative cancer therapies through collaboration with patients, scientists, and pharmaceutical partners.

Positive
  • None.
Negative
  • None.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the virtual SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 10:00 a.m. ET / 7:00 a.m. PT.

Live audio webcast of the presentation will be accessible and available for replay from the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime Therapeutics

Five Prime is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com.

Source: Five Prime Therapeutics, Inc.

FAQ

What event will Five Prime Therapeutics participate in on February 25, 2021?

Five Prime Therapeutics will participate in the SVB Leerink 10th Annual Global Healthcare Conference.

Who are the speakers from Five Prime Therapeutics at the conference?

Tom Civik, President and CEO, and Helen Collins, M.D., Executive VP and CMO, will speak.

Where can I listen to the Five Prime Therapeutics conference presentation?

The presentation will be available via live audio webcast on the company’s website.

How long will the Five Prime Therapeutics webcast be available for replay?

The archived replay will be available for 30 days after the conference.

What is Five Prime Therapeutics focused on?

Five Prime is focused on developing novel therapies for cancer, striving to improve treatment options.

FPRX

NASDAQ:FPRX

FPRX Rankings

FPRX Latest News

FPRX Stock Data

45.24M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
South San Francisco